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Whole-body coolingComplex regional pain syndrome (CRPS) is characterised by autonomic, sensory, and motor disturbances. The
underlying mechanisms of the autonomic changes in CPRS are unknown. However, it has been postulated
that sympathetic inhibition in the acute phase with locally reduced levels of noradrenaline is followed by an
up-regulation of alpha-adrenoceptors in chronic CRPS leading to denervation supersensitivity to catecholamines.
This exploratory study examined the effect of cutaneous sympathetic activation and inhibition on cutaneous
noradrenaline release, vascular reactivity, and pain in CRPS patients and in healthy volunteers. Seven patients
and nine controls completedwhole-body cooling (sympathetic activation) and heating (sympathetic inhibition)
induced by awhole-body thermal suitwith simultaneousmeasurement of the skin temperature, skin bloodflow,
and release of dermal noradrenaline. CRPS pain and the perceived skin temperatureweremeasured every 5 min
during thermal exposure, while noradrenaline was determined from cutaneous microdialysate collected every
20 min throughout the study period. Cooling induced peripheral sympathetic activation in patients and controls
with significant increases in dermal noradrenaline, vasoconstriction, and reduction in skin temperature. The
main findings were that the noradrenaline response did not differ between patients and controls or between
the CRPS hand and the contralateral unaffected hand, suggesting that the evoked noradrenaline release from
the cutaneous sympathetic postganglionic fibres is preserved in chronic CRPS patients.
© 2013 Elsevier Inc. All rights reserved.Introduction
Complex regional pain syndrome (CRPS) is a heterogeneous pain con-
dition characterised by pain, autonomic disturbances, trophic changes,
and reduced motor function in the affected limb (Veldman et al., 1993).
CRPS pain has been attributed to abnormal activity of the sympathetic
nervous system due to clinical features with disturbances in autonomic
functions such as the regulation of skin temperature, colour, blood flow,E, noradrenaline; NRS, numeric
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l. (2013), http://dx.doi.org/10and sweat secretion, as well as the occurrence of oedema (Veldman et
al., 1993).
A number of findings have indicated that peripheral noradrena-
line (NE) release plays a central role in CRPS. Firstly, intradermal
injection of NE evokes pain in patients with sympathetically
maintained pain (Ali et al., 2000). Secondly, spontaneous and evoked
pain increases following sympathetic arousal (Drummond et al., 2001)
and during physiological activation of cutaneous vasoconstrictor neurons
projecting to the CRPS limb (Baron et al., 2002). Thirdly, lower plasma
levels of NE (Drummond et al., 1991; Harden et al., 1994; Wasner et al.,
1999) and its neuronal metabolite 3,4-dihydroxyphenylethyleneglycol
(Drummond et al., 1991) have been detected in the painful limb com-
pared with the contralateral limb in patients with CRPS. Finally, Arnold
et al. (1993) reported an increased alpha-adrenoceptor responsiveness
of the dorsal superficial hand veins in CRPS. Based on these findings, it
has been suggested that partial sympathetic denervation in the acute
phase with locally reduced levels of NE is followed by an up-regulation
of alpha-adrenoceptors on sensory fibres (possibly on nociceptive fibres)easured by microdialysis in complex regional pain syndrome during
.1016/j.expneurol.2013.01.017
2 A.J. Terkelsen et al. / Experimental Neurology xxx (2013) xxx–xxxin the chronic stage of CRPS (Drummond et al., 1991). Indeed a small
autoradiographic study of five CRPS patients found a greater density
of alpha1-adrenoceptors in the epidermis and upper dermis of patients'
hyperalgesic skin compared to the skin of healthy controls (Drummond
et al., 1996).
While these findings suggest that local NE plays a pathophysiological
role in CRPS, the evidence for pain relief by sympathectomy in CRPS is
limited. So far, there is no evidence from randomised, double-blinded,
controlled trials on the efficacy and safety of chemical and surgical
sympathectomy for neuropathic pain (Furlan et al., 2000; Straube et al.,
2010). Similarly, the evidence for pain relief in CRPS by local anaesthetic
sympathetic blocks is scarce (Cepeda et al., 2005).
Therefore, it is still unclear whether NE is changed locally at the site
of injury andwhether it plays a role in themaintenance of pain in CRPS.
To determine the possible role of NE in the pain associatedwith CRPS, it
is necessary to measure NE levels under controlled conditions in the
vicinity of dermal nociception in areas with evoked pain. One way to
achieve this is to “clamp” the peripheral sympathetic nervous system
and measure the release of NE to the skin when the sympathetic ner-
vous system is either activated or inhibited.
Whole-body cooling is a known physiological stimulus that effec-
tively activates peripheral cutaneous sympathetic fibres resulting in
the release of cutaneous NE (Bini et al., 1980a). Thus, in the present ex-
ploratory study, cutaneous NE was measured in the hyperalgesic zone
by microdialysis during rest and during whole-body cooling and
heating in patients with CRPS as well as in a gender- and age-matched
group of healthy controls. The primary aim was to study NE regulation
during cooling and heating in patients and to compare the NE levels
to those of healthy controls. The secondary aim was to test for a corre-
lation between changes in NE release and CRPS pain. The level of sym-
pathetic activation was evaluated by various autonomic measures.
Materials and methods
Ethical approval
The study conformed to the standards set by the latest revision of the
Declaration of Helsinki and was approved by the Local Ethics Committee
(No. 20050192) and The Danish Data Protection Agency. The patients
and healthy controls received written and oral information about the
study and gave their written informed consent.
Subjects
The inclusion criteria were: At least 18 years of age and a normal
ECG. Participants did not receive pharmacological treatment potentially
affecting the vascular or autonomic systems. Thus, no included patient
was tested for sympatheticallymaintained pain prior to the experiment.
Pregnant or lactatingwomenwere excluded, as were patients with car-
diovascular or endocrine diseases (including diabetes), malignancies,
acute or chronic infections (including known human immunodeficien-
cy virus infection), known alcohol or drug abuse, or pain conditions
other than the CRPS.
Ten CRPS patients attending the Neuropathic Pain Clinic at Aarhus
University Hospital, Aarhus, Denmark were included. The patients had
symptoms in one upper limb and fulfilled the ‘Budapest’ research diag-
nostic criteria for CRPS (Bruehl et al., 1999). Three patients did not com-
plete the thermal exposure; one stopped after baseline measurements
due to spontaneous pain aggravation before the thermal exposure, one
stopped after baseline and cooling due to severe evoked pain, and one
could not finish the cooling session due to cold hyperalgesia on the
chest but completed the baseline and heating measurements. Thus,
seven patients completed the thermal exposure.
Ten age- and gender-matched healthy volunteers were recruited by
advertising at Aarhus University Hospital. The inclusion criteria were aPlease cite this article as: Terkelsen, A.J., et al., Cutaneous noradrenaline m
whole-body cooling and heating, Exp. Neurol. (2013), http://dx.doi.org/10normal medical history and physical examination. One healthy control
did not complete the cooling and heating sessions due to discomfort.
Medical pain history and clinical examination
Themedical historywas obtained, and the patients rated their sponta-
neous limb pain, the average limb pain within the last 24 h, and the
highest limb pain intensity during the last 24 h on a numeric rating
scale (NRS) from 0 to 10 (0=no pain, 10=maximal imaginable pain).
Each patient marked the area of spontaneous pain on a body chart. The
neurological examinationwas supplementedwith a sensory examination
that mapped the areas of pinprick hyperalgesia and brush allodynia.
Pinprick hyperalgesia was defined as increased pain induced by a
von Frey monofilament (745 mN, Semmes-Weinstein, Stoelting, IL) and
assessed in distributional steps of 10 mm. Brush allodynia or dysesthesia
was induced by brushing at 5 cm/s (SENSELab, Brush-05, Somedic Sales
AB, Hörby, Sweden) in similar steps.
Whole-body cooling and heating and ratings of subjective skin tempera-
ture during the thermal challenge
A thermal suit covering the whole body apart from the feet, fore-
arms, head, and neck was used to induce whole-body cooling and
heating (Baron et al., 2002). The forearms were not covered by the
suit to avoid direct heating and cooling of the area of microdialysis. Cir-
culating water of either 5 °C or 50 °C induced, respectively, cooling
(sympathetic activation with high cutaneous vasoconstriction) and
heating (sympathetic inhibition with low cutaneous vasoconstriction).
During the thermal exposure the patients and controls every 5 min
rated their perceived skin temperature on a scale from −4 to +4
(McAllen et al., 2006): +4 very hot, +3 hot, +2 warm, +1 slightly
warm, 0 neutral, −1 slightly cool, −2 cool, −3 cold, and −4 very
cold. The cooling and heating sessions each continued for at least
40 min until the skin temperature of the unaffected limb was below
26 °C and the participant gave a rating of −4 very cold or until the
skin temperaturewasmore than 34 °C and the participant gave a rating
of+4 very hot, respectively. If an unacceptable level of pain or unpleas-
antness occurred before reaching 26 °C and a rating of −4 or before
reaching 34 °C and a rating of +4 further cooling and heating was
stopped. However, on all occasions participants finalized the ongoing
20 min session for the collection of the microdialysis perfusate.
Dermal microdialysis
Sterile microdialysis probes with a membrane diameter/length of
0.5/30 mm and a molecular weight cut-off of 20 kDa (CMA 66, CMA
Microdialysis AB, Solna, Sweden) were inserted intradermally in the
dorsum of the hand between the first and second metacarpal bone of
both hands carefully avoiding damage to the visible cutaneous vessels.
In CRPS patients, the microdialysis probes were inserted at skin sites
with spontaneous or evoked pain (Fig. 1). An ice pack was placed on
the skin for approximately 1 min before the insertion of the probe to
avoid haematoma and to induce slight analgesia. The skin was swabbed
with ethanol 70% before intradermal insertion of the guide cannula (21
Gauge) to a length of 40 mm, ensuring that the dialysis membrane was
covered by skin along its entire length. The probes were perfused with
sterile Ringers solution at 20 μl/min for 5 min and then 2 μl/min using
amicrodialysis pump (CMA402, CMAMicrodialysis AB, Solna, Sweden).
No samples were collected for the first hour after the insertion of the
probes (the trauma phase). Subsequently, samples were collected
every 20 min throughout the study period. Samples of 40 μl dialysate
were collected into light-impermeable vials containing 4 μl of a solution
with EGTA (Merck KGaA, Darmstadt, Germany) and reduced glutathi-
one (Merck KGaA, Darmstadt, Germany). The vials were placed in ice
water during the sampling of the dialysate and immediately frozen at
−80 °C until analysis.easured by microdialysis in complex regional pain syndrome during
.1016/j.expneurol.2013.01.017
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Fig. 1. Areas (posterior dimensions) of spontaneous and evoked pain (pinprick hyperalgesia and brush allodynia) in patients with complex regional pain syndrome (CRPS). The
microdialysis probe was placed in an area with spontaneous or evoked pain.
3A.J. Terkelsen et al. / Experimental Neurology xxx (2013) xxx–xxxTo confirm the ability of the microdialysis technique to monitor
human intradermal NE changes, pilot experiments (two probes, one
subject) were performed with intra-probe delivery of tyramine (Leis
et al., 2004) (VWR — Bie & Berntsen, Herlev, Denmark). Tyramine is
an indirect sympathomimetic preventing NE reuptake and displacing
NE from neuronal storage vesicles (Burgen and Iversen, 1965). Tyra-
mine (10 μg/ml) infused for 20 min increased dermal levels of NE
more than 10-fold over the baseline levels of NE (data not shown).
Analysis of NE
Concentrations of NE in the skin microdialysis samples were deter-
mined with HPLC with electrochemical detection based on a slight mod-
ification of the method as described elsewhere (Yoshitake et al., 2010).
Briefly, the HPLC system consisted of a HTEC500 liquid chromatograph,
including an electrochemical detector (Eicom, Kyoto, Japan), a CMA/200
Refrigerated Microsampler (CMA Microdialysis, Stockholm, Sweden),
and a Clarity data acquisition system (DataApex, Prague, The CzechPlease cite this article as: Terkelsen, A.J., et al., Cutaneous noradrenaline m
whole-body cooling and heating, Exp. Neurol. (2013), http://dx.doi.org/10Republic). The potential of the glassy carbon working electrode was
set to +450 mV vs. the Ag/AgCl reference electrode. NE was separated
on an Eicompak CAX (200×2.0 mm; Eicom) column using a mobile
phase consisting of 10% methanol and 90% of 0.1 M phosphate buffer
(pH 6.0) and containing 15 mM potassium chloride and 65 μM
EDTA-2Na. The detection limit (signal-to-noise ratio=3) for NE was
0.05 nM, that is 0.75 fmol in 15 μl injected onto the column.
Cutaneous blood flow and temperature
Skin blood flow and temperature were measured continuously with
two laser Doppler flowmeters (LDF) with combined optic/temperature
probes placed bilaterally at the pulp of the first finger (MoorVMF, Moor
Inc., Axminster, Devon, UK; 40 Hz) and bilaterally on the dorsum of the
hands in the area of microdialysis (DRT4, Moor Inc., Axminster, Devon,
UK; 1 Hz). The LDF probes were attached to the skin using double-
adhesive tape and adequate probe holders. LDF arbitrary perfusion units
(a.u.) and skin temperature (data not shown) were averaged for periodseasured by microdialysis in complex regional pain syndrome during
.1016/j.expneurol.2013.01.017
Silence Silence
Baseline
HeatingCooling
Skin temperature and flux
Blood pressure
Heart rate
Silence
Time
Microdialysis dialysate
collected every 20 min 
Pain NRS(0-10) andperceived 
skin temperature NRS(-4-+4)
Core temperature
Last 20 min 
of cooling
Last 20 min 
of heating
Fig. 2. Experimental set-up. Measurements were performed during baseline (20 min
supine rest), cooling, and heating. Tenmin of silence occurred during baseline, and during
the last 20 min of cooling and heating duringwhich neither experimenters nor volunteers
spoke. The microdialysis dialysate was collected every 20 min throughout the experi-
ment. Pain and subjectively perceived skin temperature were rated every 5 min on
numeric rating scales (NRS), except during the silent periods. Skin temperature and flux
were measured continuously. The core temperature was measured during baseline, and
during the last 20 min of cooling and heating. Autonomic measurements obtained with
the Task Force Monitor (TFM) were performed during the silent periods. Blood pressure
was measured before baseline, after cooling, and after heating.
4 A.J. Terkelsen et al. / Experimental Neurology xxx (2013) xxx–xxxof 20 min during baseline, the last 20 min of cooling, and the last
20 min of heating for further statistical analysis. The skin temperature
was also measured manually every 5 min in digits two through five
with an infrared thermometer (IR Thermometer, IR-1000 L, Voltcraft,
Hirschau, Germany).
Core temperature
The core temperature was measured with an ear thermometer
(ThermoScan 6013, Braun, Kronberg, Germany) at baseline, and after
5 min of the last 20 min of cooling and heating.
Ratings of pain during the thermal challenge
Every 5 min during the thermal challenge, the patients rated the
pain in the affected armon an 11-point NRS (0=nopain, 10=maximal
imaginable pain).
Autonomic and hemodynamic parameters
A Task Force Monitor (CNSystems Medizintechnik AG, Graz,
Austria) non-invasively recorded the ECG (sample rate: 1000 Hz)
and oscillometric blood pressure (Fortin et al., 2006). Hemodynamic
parameters were then estimated and expressed as the mean values of
RR intervals (mean time between consecutive normal R waves in the
QRS complexes), and systolic and diastolic blood pressure.
Experimental setup
All subjects were investigated in themorning after fasting overnight
or from 3 p.m. after at least 4 h of fasting. The subjects had abstained
from physical activity for at least 24 h and caffeine-containing bever-
ages, alcohol, and smoking for at least 12 h. Subjects emptied their blad-
der before the experiments. They were examined in the supine position
in a roomwith amean temperature of 24.2 °C (range 22.5–25.8 °C). The
arms were immobilised in a semi-flexed position. Measurements of
skin temperature and flux as well as reports of pain and perceived
skin temperature were made during resting, cooling, and heating with
simultaneous collection of the microdialysis dialysate. Heart rates
were measured in silence during three 10-min periods at baseline,
and during the last 20 min of cooling and heating (Fig. 2). Recordings
were initiated 5 min after the start of the specific period.
Statistical analysis
Statistical tests and figures are based on the complete data set,
whichwas available for seven patients. For healthy controls, the statis-
tical tests and figures are based on the complete data set, which was
available for seven controls for the NE, for eight controls for the
blood pressure and flux, and for nine controls for the remaining mea-
sures. However, data from all ten patients and ten controls are includ-
ed in Figs. 3C–F. The measurements are presented as the means and
SD. Fisher's exact test was used to compare the dichotomous clinical
variables, and unpaired t-tests for differences in quantitative clinical
variables. The difference between the groups (patients and controls)
with respect to core temperature, autonomic measurements, and NE
levels during the three conditions (baseline, last 20 min of cooling
and heating) was assessed using 2-way repeated measures ANOVA,
as was the difference in NE levels between the hands in the CRPS
patients. The post hoc Wilcoxon signed-rank test was used to assess
the significant main effect of the condition (last 20 min of cooling versus
last 20 min of heating), whichwas the primary outcome. Spearman's rho
was used for correlation analysis. To test whether the NE response on the
CRPS hand differed from the contralateral hand, in each patient, the dif-
ferences in NE between the hands were calculated for each collection
point and summarised as the average difference of all measurementsPlease cite this article as: Terkelsen, A.J., et al., Cutaneous noradrenaline m
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TheWilcoxon singed rank test was used to assess if these average differ-
ences deviated significantly from zero. All statistical testswere two-sided,
and the level of significance was 5%. Stata 8.1 (StataCorp. 2003, Stata Sta-
tistical Software: Release 8.0. College Station, TX: Stata Corporation) was
used for the basic statistical calculations.
Results
Patient characteristics
The patients (mean age 47 years, SD 12 years; female/male ratio: 5/2;
body mass index 27 kg/m2, SD 4 kg/m2) and age- and gender-matched
controls (mean age 47 years, SD 14 years; female/male ratio: 4/5; body
mass index 26 kg/m2, SD 5 kg/m2) did not differ regarding weight,
height, and body mass index. The number of smoking patients (57%)
and controls (33%) did not differ (P=0.62).
The inciting events in the CRPS patients were the following: Carpal
tunnel surgery, crush injury at the proximal phalanx of digit 1, tennis
elbow surgery, ulnar nerve lesion, surgical decompression of the ulnar
nerve, comminuted fracture of the proximal humerus, and wrist distor-
tion. The patients were medicated as follows: In one patient, amitripty-
line was gradually reduced and not taken for six days prior to study
start. Four patients were taking acetaminophen, three tramadol, two
pregabalin, and one subject was treated with buprenorphine plaster,
onewith darifenacin, one with alendronate, and one with glucosamine.
The spontaneous pain, allodynia, and hyperalgesia in the CRPS patients
were distally localised and not limited to the territory of a single periph-
eral nerve (Fig. 1). The mean CRPS limb pain at the study visit was 6.2
(range 5–8). It was 6.4 (range 4.5–8) over the previous 24 h, and the
maximum pain over the previous 24 h was 8.5 (range 6–10). The
mean pain duration was 1795 (range 147–4363) days. Thus all patients
had chronic CRPS according to themost recently established criteria for
CRPS (Bruehl et al., 1999).
Cutaneous NE
For NE (Table 1, Figs. 3A and B), there was a significant condition
effect with an increases in NE during high versus low peripheral sym-
pathetic activation by a factor of 3.4 on the CRPS hand and the contra-
lateral pain-free hand. In controls, the mean NE for both hands
increased significantly by a factor of 2.3. There was no differenceeasured by microdialysis in complex regional pain syndrome during
.1016/j.expneurol.2013.01.017
Fig. 3. Cutaneous noradrenaline (NE) levels during whole-body cooling and heating. There was a significant release of NE during peripheral sympathetic activation (cooling) com-
pared to peripheral sympathetic inhibition (heating) in controls (A) and patients (B) (mean (SD)). There was no difference between the hands in the patients or the controls. For
each group the responses in the hands were similar during baseline, cooling, and heating. # One patient was only cooled for 40 min and is not included in the time period from 40 to
60 min. The data for skin temperature versus NE concentration in all included controls (C) and patients (D) show increased NE release at the lowered skin temperature. For all
included controls, NE samples collected during baseline, cooling, and heating from the right hand are plotted against the values from the left hand (E). For all included patients,
the NE samples collected during baseline, cooling, and heating from the affected hand (NE CRPS hand) are plotted against the values from the unaffected contralateral hand (NE
contra) (F).
5A.J. Terkelsen et al. / Experimental Neurology xxx (2013) xxx–xxxbetween the hands in the patients or the controls. For each group, the
responses in the hands were similar during baseline, cooling, and
heating. Comparing patients to controls (mean NE of both hands),
the responses were similar during baseline, cooling, and heating.
For patients and controls, NE levels increasedwhen the skin temper-
aturewas lowered (Figs. 3C and D). During baseline therewas no corre-
lation between mean skin temperatures and mean NE levels in the
controls (r=−0.32, P=0.21) or in the patients (r=−0.22, P=0.35).
The NE release on the CRPS hand was comparable to the contralat-
eral hand (Fig. 3E; P=0.80). The NE release was not significantly dif-
ferent in the two hands in the controls (Fig. 3F; P=0.86).Please cite this article as: Terkelsen, A.J., et al., Cutaneous noradrenaline m
whole-body cooling and heating, Exp. Neurol. (2013), http://dx.doi.org/10Modulation by whole-body cooling and heating
The mean duration of cooling in the patients was 89 min (SD 53,
range 40–200), and in the controls, it was 109 min (SD 32, range 80–
160; P=0.35). The mean length of the heating session among the pa-
tients was 97 min (SD 21, range 60–120) versus 100 min (SD 26, range
60–140) for the controls (P=0.82). Cooling and heating did not affect
the core temperature. Regarding 1) the skin temperature measured at
pulps of digits two to five (Figs. 4A and B, Table 1), 2) flux measured at
digit one (Figs. 4C and D, Table 1), and 3) flux measured near the micro-
dialysis probe (Figs. 4E and F, Table 1) there was a significant conditioneasured by microdialysis in complex regional pain syndrome during
.1016/j.expneurol.2013.01.017
Table 1
Cutaneous noradrenaline, skin temperature, and flux in patients and controls exposed to cooling and heating.
Baseline Cold Heat ANOVA (P value) Wilcoxon
Hand×condition Between-hand Condition Cold/heat
Mean noradrenaline, pg/ml (SD)
CRPS hand 56 (65) 116 (81) 35 (20) 0.75 0.99 b0.001 0.02
Contra 44 (24) 120 (66) 43 (22) 0.03
Control right 51 (17) 140 (89) 57 (14) 0.92 0.96 b0.001 0.01
Control left 57 (26) 132 (81) 55 (12) 0.02
Mean skin temperature at pulps of digit two to five, °C (SD)
CRPS hand 28.2 (4.0) 25.1 (0.9) 33.1 (2.0) 0.89 0.70 b0.001 0.02
Contra 29.0 (4.0) 25.0 (1.2) 33.4 (1.9) 0.02
Control right
Control left
31.5 (2.7) 25.2 (1.6) 33.7 (1.5) 0.60 0.36 b0.001 0.008
32.5 (2.5) 25.3 (1.3) 34.5 (0.9) 0.008
Mean flux at digit 1, a.u. (SD)
CRPS hand 145 (131) 36 (23) 301 (79) 0.73 0.21 b0.001 0.02
Contra 205 (132) 49 (59) 364 (119) 0.02
Control right
Control left
236 (114) 39 (33) 283 (99) 0.89 0.34 b0.001 0.01
195 (92) 24 (22) 260 (94) 0.01
Mean flux at dorsum hand, a.u. (SD)
CRPS hand 29 (21) 19 (14) 96 (60) 0.84 0.67 b0.001 0.02
Contra 39 (33) 15 (5) 108 (63) 0.02
Control right 44 (34) 15 (6) 90 (50) 0.78 0.59 b0.001 0.01
Control left 32 (12) 14 (5) 58 (25) 0.01
Measurements performed during 20 min rest (baseline), during last 20 min of cooling (cold), and last 20 min of heating (heat). CRPS hand=painful hand in the patients, Contra=
contralateral non-painful hand in the patients.
6 A.J. Terkelsen et al. / Experimental Neurology xxx (2013) xxx–xxxeffect in both groups with a lower skin temperature and flux during cold
compared to heat. There was no difference between the hands in the
patients or the controls, and for each group, the responses in the hands
were similar during baseline, cooling, and heating. Comparing patients
to controls (mean skin temperature and flux of both hands), the re-
sponses were similar during baseline, cooling, and heating. For the sub-
jective appraisals of skin temperature (Fig. 4G), there was a significant
condition effect with lower experienced skin temperature during cooling
compared with heating. There was no difference between the reports in
patients and controls, and the responses in the groups were similar dur-
ing baseline, cooling, and heating.Pain ratings during thermal exposure
Themean pain rated on anNRSwas 6.2 (SD 1.7) during baseline and
increased to 8.5 (SD 1.8) during the last period of cooling (Fig. 4H). For
all patients, the pain intensity during cooling was higher than during
baseline (P=0.02). Five of the seven patients completing the thermal
exposure had a reduction in pain associated with the change from
high to low sympathetic activation. The reduction to 7.2 (SD 2.5) during
the last period of heating was not significant compared to that during
the last period of cooling (P=0.24). There was no correlation between
changes in NE release and pain score during high versus low peripheral
sympathetic activation (r=−0.11, P=0.78).Hemodynamic changes
For systolic and diastolic blood pressure, there was a significant
condition effect with significantly higher systolic blood pressure dur-
ing cooling versus heating in patients, but not in controls (Table 2).
Diastolic blood pressure was higher during cooling compared to
heating in both groups. For the mean RR, there was a significant con-
dition effect with higher mean RR values during cooling compared to
heating in patients and controls.Please cite this article as: Terkelsen, A.J., et al., Cutaneous noradrenaline m
whole-body cooling and heating, Exp. Neurol. (2013), http://dx.doi.org/10Discussion
Whole-body cooling induced a significant increase in cutaneous NE
release, vasoconstriction, and lowered skin temperature. Themain find-
ing in this exploratory study was that these responses were similar in
CRPS patients and in healthy controls and between the affected and
contralateral side in the CRPS patients. The similar magnitude of NE
release in both CRPS patients and controls suggests that the evoked
NE release from cutaneous sympathetic postganglionic fibres in chronic
CRPS in general is preserved.
The present microdialysis study has, for the first time, measured
dermal NE directly in the zone of spontaneous and evoked pain in
CRPS patients. The patients and controls were exposed to cutaneous
sympathetic activation (whole-body cooling) and inhibition (whole-
body warming) as determined by changes in skin temperature and
blood flow. The NE concentration was increased by a factor of 3 with
significantly higher NE values during physiological activation of the
peripheral cutaneous sympathetic fibres (cooling) compared to a low
peripheral sympathetic activity during heating. The increase in NE is
identical to previously reported subcutaneous NE release during cold
exposure in healthy volunteers (Gronlund et al., 1994). This suggests
that the dermal microdialysis with the measurement of NE is a valid
method to evaluate changes in local sympathetic activity during physi-
ological manipulations of sympathetic activity. The NE responses are
dynamic, and may change with the duration of heating or cooling. In
the present study, the data were plotted during the entire thermal
cycle from baseline through increasing coldness and warmness (Figs.
3C and D). No differences were found. Therefore, it is unlikely that the
long duration of heating and cooling could have interfered with any
difference between the hands or between the patients and controls.
We used microdialysis technique to assess skin concentrations of
NE, which we measured in dialysate recovered from the skin. The
dialysate recovered a constant proportion of the solute in the skin
known as relative recovery. It is generally accepted that relative
recovery largely depends on the length and the diameter of the mi-
crodialysis membrane, the membrane material, the flow rate, theeasured by microdialysis in complex regional pain syndrome during
.1016/j.expneurol.2013.01.017
Fig. 4. Skin temperature, flux, and subjectively perceived skin temperature were reduced by cooling and increased by heating. Manual skin temperature was measured at digits two
to five in the controls (A) and patients (B) (mean (SD)). Mean cutaneous flux at digit one in the controls (C) and patients (D). Mean cutaneous flux near the microdialysis probe at
the dorsum of the hands in controls (E) and patients (F). Subjectively perceived skin temperature (G) (mean (SD)) rated on a −4 to +4 numeric rating scale (NRS); +4: very hot;
+3: hot; +2: warm; +1: slightly warm; 0: neutral; −1: slightly cool; −2: cool; −3: cold; −4: very cold. Pain in the CRPS hand (H) rated on a NRS (0–10). Pain was not rated
during the silent periods, explaining the missing NRS values after 10, 70, 90, and 170 min. # One patient was only cooled for 40 min and is not included in the time period from
40 to 60 min.
7A.J. Terkelsen et al. / Experimental Neurology xxx (2013) xxx–xxxsubstance evaluated, and the target tissue investigated (Holmgaard et
al., 2010). All but the skin composition was identical in patients and
controls. The skin in the affected tissue in CPRS patients may be
changed due to oedema, which in theory could influence the relative
recovery. This potential issue may compromise direct comparisons of
the dialysate NE concentrations during baseline in patients and con-
trols. The effect of oedema on relative recovery in the skin has not
been thoroughly investigated. Langberg et al. (1999) demonstratedPlease cite this article as: Terkelsen, A.J., et al., Cutaneous noradrenaline m
whole-body cooling and heating, Exp. Neurol. (2013), http://dx.doi.org/10no difference in relative recovery in Achilles tendons immediately
after probe insertion, after a 180 min running period and after
3 days of recovery. Also experimental studies in CRPS patients have
shown that the short-lasting protein extravasation (an indicator of
oedema) caused by probe implantation was identical in CPRS patients
and controls in terms of peak response and elimination despite the
presence of oedema in the skin of the patients but not the controls
(Weber et al., 2001).easured by microdialysis in complex regional pain syndrome during
.1016/j.expneurol.2013.01.017
Table 2
Heart rate, blood pressure, and core temperature in controls and patients exposed to cooling and heating.
Baseline Cold Heat ANOVA (P value) Wilcoxon
Condition×group Between-group Condition Cold/heat
Mean RR, ms (SD)
Controls 1048 (172) 1035 (98) 850 (96) 0.93 0.35 b0.001 0.008
Patients 966 (204) 964 (239) 791 (118) 0.04
Mean systolic blood pressure, mm Hg (SD)
Controls 120 (9) 129 (10) 129 (11) 0.11 0.40 0.002 0.94
Patients 128 (17) 140 (26) 128 (13) 0.02
Mean diastolic blood pressure, mm Hg (SD)
Controls 78 (10) 88 (10) 82 (9) 0.13 0.96 0.002 0.04
Patients 83 (12) 87 (16) 79 (9) 0.03
Mean core temperature, °C (SD)
Controls 36.9 (0.4) 36.9 (0.5) 36.8 (0.5) 0.51 0.86 0.86 0.63
Patients 36.8 (0.3) 36.9 (0.4) 37.0 (0.7) 0.93
Measurements performed during 20 min rest (baseline), during last 20 min of cooling (cold), and last 20 min of heating (heat). Mean RR interval=mean time between consecutive
normal R waves in the QRS complexes.
8 A.J. Terkelsen et al. / Experimental Neurology xxx (2013) xxx–xxxWe do realize that vascular tone may influence dialysate NE
concentrations (even though relative recovery is constant). During
hypoperfusion, extracellular solute concentrations may increase
due to reduced washout/elimination (Boutsiouki et al., 2001; Ross
et al., 2006). The skin flux measured near the microdialysis probe was
significantly changed during the thermal exposure. However, there was
no difference in flux between the hands or between patients and controls
suggesting that local flow changes were without any significance in
the present comparisons. Thus, we consider it appropriate to compare
baseline dialysate NE concentrations as well as temperature-dependent
changes in dialysate NE concentrations among patients and controls.
We did not measure the relative recovery in vivo. Leis et al. (2004)
performed dermal microdialysis by measuring NE at baseline and after
infusion of tyramine in healthy volunteers. Their baseline NE levels of
36 pg/ml were lower than in the present study. They calculated an in
vivo recovery of 8% using the no-net-flux method (Leis et al., 2004). We
used a slower perfusion velocity (2 versus 4 μl/min) and a longer mem-
brane (30 versus 15 mm) with an expected higher NE recovery than
8%. A conservative approach with a recovery of 10–20% would result in
baseline skin NE levels in the range 250 to 500 pg/ml. Taken together,
we believe that the present method is sufficient to assess the relative
changes of skin NE during thermal cooling and heating.
Overall theNEwas not reduced in the present series of CRPSpatients
compared to controls, which is in contrast to previous findings of lower
venous plasma NE in the affected CRPS limb versus the unaffected limb
(Drummondet al., 1991;Harden et al., 1994;Wasner et al., 1999). How-
ever, plasmaNEmainly reflectsmuscular sympathetic activity. Further-
more, the extraction of NE fromplasma and the overflowof NE from the
sympathetic nerves to the circulation (10–20%) may depend on region-
al changes in blood flow. Therefore, to obtain a picture of the levels of
NE released in the vicinity of the dermal nociceptors in areas with
evoked pain, the present intradermal microdialysis is preferable, and
cutaneous and venous NE are not comparable.
It may be argued that the NE is reduced only in the acute (warm)
phase of CRPS (Drummond et al., 1991). The present study included
chronic CRPS patients with pain duration of more than three months.
Therefore, a future identical study should compare the regulation in
acute versus chronic CRPS.
Wemeasured skin temperature and flux bilaterally in both glabrous
(digits) and hairy (area of microdialysis) skin during the thermal expo-
sure. In glabrous skin the thermoregulatory reflexes aremainly regulat-
ed by the variation in the sympathetic vasoconstrictor tone while the
thermoregulatory reflexes in human hairy skin are mediated byPlease cite this article as: Terkelsen, A.J., et al., Cutaneous noradrenaline m
whole-body cooling and heating, Exp. Neurol. (2013), http://dx.doi.org/10two branches of the sympathetic nervous system (noradrenergic va-
soconstrictor nerves and cholinergic active vasodilator nerves) (Bini
et al., 1980b). We have presented skin temperature data for both hairy
and glabrous skin (Fig 4). The skin temperature and flux in glabrous
skin reflect changes in noradrenergic sympathetic vasoconstrictor nerves
and for that reason we correlated these measures to changes in NE
release.
The baseline skin temperature was three degrees colder in the pa-
tients compared with the controls despite similar baseline NE levels.
The correlation between baseline skin temperature and NE levels was
not significant in patient or controls and the correlation coefficients
were almost equal in the two groups. Thus, the NE levels were not
less in the perfusate in the controls at baseline all other factors being
equal. The difference in skin temperature was not statistically signifi-
cant but this could be clinically meaningful. It is well known that the
lowering of temperature may affect nerve function, e.g. conduction
velocity (Buchthal, 1991).
The pain reduction was not correlated with a reduction in NE
release. However, for all patients, the pain intensity during cooling
was higher than during baseline, and five of the seven patients who
completed the thermal exposure had reduced pain scoreswhenmoving
from high to low peripheral sympathetic activation. This is a secondary
outcome but is compatible with the notion that NE released from
sympathetic fibres may cause pain as observed in conditions termed
sympathetic maintained pain (Price et al., 1998; vanEijs et al., 2012).
The present study did not include a control group with pain other
than CRPS and cannot rule out whether the thermal induced changes
in pain are unique to CRPS or do occur in other pain patients.
The systolic blood pressure in the patients and the diastolic blood
pressure in both groups were higher and the heart rate was lower in
both groups during whole-body cooling than during whole-body
heating. Therefore, cooling and heating not only modulated the cuta-
neous sympathetic fibres, but it most likely also modulated sympa-
thetic fibres innervating vessels in the skeletal musculature as well
as efferent cardiac sympathetic and parasympathetic fibres. There-
fore, the higher pain in the patients during cooling may also be relat-
ed to sympathetic activation of deeper somatic tissues. There seem to
be further mechanisms apart from NE in which sympathetic neurons
are involved in nociception (Green et al., 1997). We did not test for
other possible explanations for sympathetic mediated pain in CRPS,
such as changes in the co-release of other substances together with
NE, reduced degradations of transmitters in the milieu of the sensory
nerves due to reduced regional cutaneous flow, or sensitisation ofeasured by microdialysis in complex regional pain syndrome during
.1016/j.expneurol.2013.01.017
9A.J. Terkelsen et al. / Experimental Neurology xxx (2013) xxx–xxxcutaneous nociceptive C fibres to adrenergic excitation. In our cohort,
the evoked NE release from cutaneous sympathetic postganglionic
fibres was in general preserved suggesting that the NE levels are not
the culprit in the sympathetic mediated pain. In line with this recent
evidence rather points to a sensitization of adrenergic receptors than
to an increased efferent sympathetic activity. Particularly the sensiti-
zation of alpha 1-adrenoceptors on cutaneous nociceptive C-fibres
may play a major role independent of the NE levels (Campbell et al.,
1992; Dawson et al., 2011). It is possible that additional information
would have been obtained if skin punch biopsies had been carried out
to study a change in alpha1-adrenoceptor density in affected skin versus
control skin (Drummond et al., 1991) and quantification of sudomotor
and sensory nerves would have provided additional evidence.
The core temperature was not changed in the two groups during
cooling and heating as previously described (Baron et al., 2002). This
suggests that the participants had effective mechanisms to regulate
heat loss and heat production and tomaintain body temperaturewithin
a limited range. An increased core temperature is known to induce sig-
nificant increases in plasma NE (Rowell, 1990; Wright et al., 2010)
underlining the importance of an unchanged core temperature in the
present set-up modulating cutaneous sympathetic activity.
Conclusion
This study is the first tomeasure cutaneousNEdirectly in the zone of
evoked pain during physiological modulation of the peripheral sympa-
thetic nervous systemwithwhole-body cooling and heating in CRPS pa-
tients. No differences in cutaneous NE were found in patients and
controls or between the affected and unaffected CRPS hand, suggesting
that the evoked NE release from cutaneous sympathetic postganglionic
fibres in CRPS is preserved in chronic CRPS. The study calls for additional
studies in which acute and chronic CRPS is taken into consideration.
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